Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TripleW has developed and commercialized a proprietary process that converts food waste into high-purity lactic acid, which serves as a building block for biodegradable bioplastics such as PLA. The company claims to be the first to sell food-waste-based lactic acid commercially. Their technology also enables chemical recycling of PLA back into their process, supporting circular economy goals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TripleW.